Yıl: 2022 Cilt: 6 Sayı: 1 Sayfa Aralığı: 89 - 91 Metin Dili: İngilizce DOI: 10.14744/ejmo.2022.91216 İndeks Tarihi: 18-06-2022

Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?

Öz:
Sarcoid like reaction is an interesting entity in cases treated by checkpoint inhibitor treatment and suggests a good response to therapy. Here a case with granulomatous reaction has been reported in a case with malignant mesothelioma treated by nivolumab. This entity may simulate disease progression by imaging modalities especially in PET/CT.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Hiraki T, Hatanaka M, Arimura A, Kawahira H, Kirishima M, Kitazono M, et al. Granulomatous/sarcoid-like reactions in the setting of programmed cell death-1 inhibition: a potential mimic of disease recurrence. J Cutan Pathol 2020;47:154-60.
  • 2. Hersey P, Karikos D, Shannon K, Van Hal S, Carr U, Crotty A, et al. Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis. Int J Rheum Dis 2017:20;1277–85.
  • 3. Tetzlaff MT, Nelson KC, Diab A, Staerkel GA, Nagarajan P, Torres-Cabala CA, et al. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. J Immunother Cancer 2018;6:14.
  • 4. van Baar MLM, Guminski AD, Ferguson PM, Martin LK. Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation. JAAD Case Rep 2019;5:491-4.
  • 5. Li Z, Graf N, Herrmann K, Jünger A, Aichler M, Feuchtinger A, et al. FLT-PET is superior to FDG-PET for veryearly response prediction in NPM-ALK-positive lymphoma treated with targeted therapy. Cancer Res 2012;72:5014–24.
APA PAYDAS S, TUNCER I, GUZEL A, PARSAK C, GUNEY I (2022). Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. , 89 - 91. 10.14744/ejmo.2022.91216
Chicago PAYDAS Semra,TUNCER Ilhan,GUZEL Ahmet Baris,PARSAK Cem Kaan,GUNEY Isa Burak Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. (2022): 89 - 91. 10.14744/ejmo.2022.91216
MLA PAYDAS Semra,TUNCER Ilhan,GUZEL Ahmet Baris,PARSAK Cem Kaan,GUNEY Isa Burak Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. , 2022, ss.89 - 91. 10.14744/ejmo.2022.91216
AMA PAYDAS S,TUNCER I,GUZEL A,PARSAK C,GUNEY I Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. . 2022; 89 - 91. 10.14744/ejmo.2022.91216
Vancouver PAYDAS S,TUNCER I,GUZEL A,PARSAK C,GUNEY I Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. . 2022; 89 - 91. 10.14744/ejmo.2022.91216
IEEE PAYDAS S,TUNCER I,GUZEL A,PARSAK C,GUNEY I "Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?." , ss.89 - 91, 2022. 10.14744/ejmo.2022.91216
ISNAD PAYDAS, Semra vd. "Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?". (2022), 89-91. https://doi.org/10.14744/ejmo.2022.91216
APA PAYDAS S, TUNCER I, GUZEL A, PARSAK C, GUNEY I (2022). Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. Eurasian Journal of Medicine and Oncology, 6(1), 89 - 91. 10.14744/ejmo.2022.91216
Chicago PAYDAS Semra,TUNCER Ilhan,GUZEL Ahmet Baris,PARSAK Cem Kaan,GUNEY Isa Burak Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. Eurasian Journal of Medicine and Oncology 6, no.1 (2022): 89 - 91. 10.14744/ejmo.2022.91216
MLA PAYDAS Semra,TUNCER Ilhan,GUZEL Ahmet Baris,PARSAK Cem Kaan,GUNEY Isa Burak Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. Eurasian Journal of Medicine and Oncology, vol.6, no.1, 2022, ss.89 - 91. 10.14744/ejmo.2022.91216
AMA PAYDAS S,TUNCER I,GUZEL A,PARSAK C,GUNEY I Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. Eurasian Journal of Medicine and Oncology. 2022; 6(1): 89 - 91. 10.14744/ejmo.2022.91216
Vancouver PAYDAS S,TUNCER I,GUZEL A,PARSAK C,GUNEY I Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?. Eurasian Journal of Medicine and Oncology. 2022; 6(1): 89 - 91. 10.14744/ejmo.2022.91216
IEEE PAYDAS S,TUNCER I,GUZEL A,PARSAK C,GUNEY I "Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?." Eurasian Journal of Medicine and Oncology, 6, ss.89 - 91, 2022. 10.14744/ejmo.2022.91216
ISNAD PAYDAS, Semra vd. "Sarcoid-Like Reaction Mimicking Disease Progression Associated with Nivolumab in a Case with Malignant Mesothelioma: Is There a Solution for This Dilemma?". Eurasian Journal of Medicine and Oncology 6/1 (2022), 89-91. https://doi.org/10.14744/ejmo.2022.91216